The twoXAR team is dedicated to improving health on a global scale by building a profit-generating business utilizing artificial intelligence. The co-founding team is from the Stanford School of Medicine and the MIT Sloan School of Management and was brought together by a common name (though not related) and a passion for entrepreneurship and technology.


    Andrew A. Radin

    CEO & Co-Founder

    Prior to co-founding twoXAR, Andrew held Chief Technology Officer roles at several early stage companies where he managed teams as large as a hundred technologists distributed around the world. Andrew developed the company's proprietary algorithm and as Chief Executive Officer is focused on overall company strategy, product development and fundraising. Andrew studied biomedical informatics in Stanford University's SCPD graduate program and holds Master of Science and Bachelor of Science degrees in computer science from Rochester Institute of Technology.

    Andrew M. Radin


    Andrew M. Radin formerly worked as an investor in venture and private equity funds at Macquarie Bank and has designed, built, and managed several small organizations. Andrew co-founded a mobile platform startup while at MIT. As a Co-Founder, Andrew acts as an ambassador of twoXAR to build relationships with biopharmaceutical partners and investors. Andrew holds a Master in Business Administration degree from MIT Sloan, a Bachelor of Science degree in biochemistry and cell biology from UCSD, and a Bachelor of Arts degree in economics from UCSD.

    Brian Moriarty

    Chief Financial Officer

    Brian was formerly a VP at Hewlett-Packard leading the HR group responsible for M&A and outsourcing. He also was VP of M&A at Sun Microsystems where he led over 17 transactions. He also has experience as CFO of ChartONE, a healthcare service company. Brian holds a Master in Business Administration degree from Northwestern and a Bachelor of Arts degree in both English and economics from UC Davis.



    Allen Poirson

    Senior Vice President of B​iopharmaceutical Business Development

    Allen Poirson’s previous experience includes serving as Chief Executive Officer for Sony Biotechnology, a wholly-owned subsidiary of Sony Corporation of America that develops and manufactures instruments used for researching and developing pharmaceuticals. Most recently, Allen was a Partner at Mighty Capital, a Silicon Valley-based venture capital firm, where he was responsible for investments in digital health, life science, and medical companies. Allen holds a Ph.D. in Neuroscience from Stanford University and a Bachelor of Arts degree in Vision Science from Stanford University.




    Vijay Pande, PhD

    Scientific Advisor

    Nigam Shah, MBBS, PhD

    Scientific Advisor

    Marina Sirota, PhD

    Scientific Advisor

    Judy Lewent

    Business Advisor

    Jonathan MacQuitty, PhD

    Business Advisor

    Howie Rosen

    Business Advisor

    Scott Stern, PhD

    Business Advisor